石四药集团(02005.HK)：吗啉硝唑已获中国药监局批准登记成为在上市制剂使用的原料药

Group 1 - The core point of the article is that Sihuan Pharmaceutical Group (02005.HK) has received approval from the National Medical Products Administration of China for its Metronidazole, allowing it to be used as an active pharmaceutical ingredient in marketed formulations [1] Group 2 - Metronidazole is a nitroimidazole antibiotic primarily used for treating anaerobic bacterial infections such as appendicitis and pelvic inflammatory disease [1]